Abstract Background and Aim Trends of utilization and outcomes of transcatheter aortic
valve replacement (TAVR) and surgical aortic valve replacement (SAVR) for patients on …

Background: Sarcoidosis, amyloidosis, hemochromatosis and scleroderma are the most
forms of infiltrative/non-ischemic cardiomyopathy (NICM) associated with sudden cardiac …

Background The impact of endstage renal disease (ESRD) on peripheral vascular
intervention (PVI) outcome remains incompletely elucidated. Objectives We sought to …

Objective In patients with chronic kidney disease (CKD) undergoing transcatheter aortic
valve replacement (TAVR), this study aims to elucidate (a) the bleeding risks associated with …

Introduction Chronic kidney disease (CKD), acute kidney injury (AKI) and worsening renal
function at 30 days after transcatheter aortic valve replacement (TAVR) portend poor …

Aortic stenosis (AS) and renal dysfunction share risk factors and often occur simultaneously.
The influence of renal dysfunction on the prognosis of patients with various grades of AS has …

Most risk prediction models for outcomes after transcatheter aortic valve replacement
(TAVR) have identified renal impairment as an important risk factor for earlier mortality (1, 2) …

Percutaneous structural interventions have a major impact on the morbidity, mortality, and
quality of life of patients by providing a lower-risk alternative to cardiac surgery. However …

Patients with end-stage renal disease (ESRD) on dialysis have a high risk of developing
aortic stenosis. They tend to develop the disease earlier than the nondialysis population (1) …

Bleeding events still represent 1 of the main concerns for patients undergoing transcatheter
aortic valve replacement(TAVR). Bleeding can complicate the periprocedural course or arise …